PMID- 7639325 OWN - NLM STAT- MEDLINE DCOM- 19950912 LR - 20181113 IS - 0002-9440 (Print) IS - 1525-2191 (Electronic) IS - 0002-9440 (Linking) VI - 147 IP - 2 DP - 1995 Aug TI - Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. PG - 251-66 AB - This study sought evidence for apoptosis, a form of programmed cell death, in human atheromatous coronary and carotid arteries. Markers for apoptotic cells included in situ terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL), genomic DNA electrophoresis, and morphological analysis. Intimal lesions contained more TUNEL+ cells (34 +/- 6%, n = 8) than non-atherosclerotic arterial intima (8 +/- 3%, n = 5, P < 0.05). The tunica media of the diseased arteries had a percentage of TUNEL+ cells (5 +/- 1%) similar to that in the normal vessels (3 +/- 1%, N.S.). Oligonucleosomal DNA fragments were visualized in extracts from 12 atheromatous plaques but in none of 5 non-atherosclerotic vessels. Both smooth muscle cells (SMC) and macrophages, two major cell types in the atherosclerotic intima, bore markers of apoptosis, but with different patterns, as determined by double histochemical labeling for cell types and TUNEL. The TUNEL+ SMC localized mainly in the fibrotic portion of the atheroma, whereas TUNEL+ macrophages clustered near or within the lipid-rich core of the lesion. Atheromatous lesions expressed mRNA encoding interleukin-1 beta-converting enzyme (ICE), a mammalian cell death gene, as demonstrated by reverse transcriptase polymerase chain reaction. Immunohistochemistry revealed that ICE localized in regions of TUNEL+ SMC and macrophages. TUNEL- cells showed little or no immunoreactive ICE. These data point to a role for apoptosis in regulation of cell accumulation during atherogenesis and suggest involvement of ICE in SMC death in fibrous regions of complex atheroma, and in macrophage death in the lipid-rich core of the lesion. Apoptosis of vascular cells in fibrous cap may impede maintenance or repair of the matrix in this region and affect stability of the plaques. FAU - Geng, Y J AU - Geng YJ AD - Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. FAU - Libby, P AU - Libby P LA - eng GR - HL-34636/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - 0 (Biomarkers) RN - 0 (Oligonucleotide Probes) RN - 0 (RNA, Messenger) RN - EC 3.4.22.- (Cysteine Endopeptidases) RN - EC 3.4.22.36 (Caspase 1) SB - IM CIN - Am J Pathol. 1995 Aug;147(2):229-34. PMID: 7639321 MH - *Apoptosis MH - Arteries MH - Arteriosclerosis/genetics/*metabolism/*pathology MH - Base Sequence MH - Biomarkers MH - Caspase 1 MH - Coronary Vessels/metabolism/pathology MH - Cysteine Endopeptidases/genetics/*metabolism MH - DNA Damage MH - Humans MH - Macrophages/pathology MH - Molecular Sequence Data MH - Muscle, Smooth, Vascular/pathology MH - Oligonucleotide Probes/genetics MH - RNA, Messenger/metabolism MH - Reference Values MH - Tissue Distribution MH - Tunica Intima/metabolism/pathology PMC - PMC1869820 EDAT- 1995/08/01 00:00 MHDA- 1995/08/01 00:01 PMCR- 1996/02/01 CRDT- 1995/08/01 00:00 PHST- 1995/08/01 00:00 [pubmed] PHST- 1995/08/01 00:01 [medline] PHST- 1995/08/01 00:00 [entrez] PHST- 1996/02/01 00:00 [pmc-release] PST - ppublish SO - Am J Pathol. 1995 Aug;147(2):251-66.